drugset / Trial / NCT02349802
Autoinjector Device Assessment Study
RandomizedParallel-groupOpen-labelTreatment
Summary
Phase I study to determine the device-related injection failure rate of the single-use, pre-filled autoinjector.
Timeline
- Start
- 2013-02
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 4.5 mg | — |
| Subject | Exenatide | Peptide | 9 mg | — |
Indications
No indication recorded.